Healthy Male

12 clinical trials · Condition

Record	Firm	Date
A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants (NCT06194500)	Eli Lilly and Company	2024-01-03
Phase I Trial of Envafolimab for Healthy Male Subjects (NCT05849311)	3D Medicines (Sichuan) Co., Ltd.	2023-05-29
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553 (NCT06105255)	InventisBio Co., Ltd	2023-05-24
Food Effect Study of IDX-1197 in Healthy Subjects (NCT05202912)	Idience Co., Ltd.	2022-01-16
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects (NCT04828265)	NGM Biopharmaceuticals, Inc	2021-04-13
A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects (NCT04135898)	Shanghai Institute Of Biological Products	2019-10-23
Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers (NCT03674060)	Samyang Biopharmaceuticals Corporation	2018-10-28
Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers (NCT03208218)	Samyang Biopharmaceuticals Corporation	2016-08-17
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers (NCT02395926)	Hyundai Pharmaceutical Co., LTD.	2013-10-01
Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg) (NCT02395913)	Hyundai Pharmaceutical Co., LTD.	2013-07-01
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers (NCT01651234)	Green Cross Corporation	2012-03-01
Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart (NCT01359618)	AstraZeneca	2011-06-01

Track Healthy Male automatically

Every clearance here is in the API, with alerts when new ones post.